| abstract |
The invention belongs to the technical field of drug preparation, and particularly relates to a pharmaceutical composition for treating benign prostatic hyperplasia and a preparation method thereof. The pharmaceutical composition for treating benign prostatic hyperplasia includes the following components in parts by weight: 39-56 parts of plant extracts, 6-10 parts of decanoylacetaldehyde, 7-12 parts of tanshinone, and 2-8 parts of paeonol. The pharmaceutical composition for the treatment of benign prostatic hyperplasia provided by the invention can quickly relieve symptoms of benign prostatic hyperplasia, has rapid onset of action, the total effective rate is as high as 91%, the course of treatment is short, the recurrence is not easy, and the pain of patients can be quickly relieved. Point treatment for benign prostatic hyperplasia. |